Você procurou por: lepirudin (Maltês - Inglês)

lepirudin
lepirudin

kull fjala fiha 20 mg lepirudin.
each vial contains 20 mg lepirudin.

kunjett wieħed fih 20 mg lepirudin.
1 vial contains 20 mg lepirudin.

huwa fih is-sustanza attiva lepirudin.
it contains the active substance lepirudin.

platelet factor 4 ma jinibixxix lepirudin.
platelet factor 4 does not inhibit lepirudin.

bħalissa, mhux disponibbli antidotu speċifiku kontra lepirudin.
currently, no specific antidote against lepirudin is available.

lepirudin huwa inibitur dirett speċifiku ħafna ta’ thrombin.
lepirudin is a highly specific direct inhibitor of thrombin.

refludan 20 mg trab għal soluzzjoni għall-injezzjoni jew infużjoni lepirudin
refludan 20 mg powder for solution for injection or infusion lepirudin

refludan 20 mg trab għal soluzzjoni għall- injezzjoni jew infużjoni lepirudin użu għal ġol- vini
refludan 20 mg powder for solution for injection or infusion lepirudin intravenous use

l-attività speċifika ta’ lepirudin hija ta’ madwar 16,000 atu/mg.
the specific activity of lepirudin is approximately 16,000 atu/mg.

refludan huwa trab abjad għal soluzzjoni għall- injezzjoni jew infużjoni pprovdut f’ kunjett li fih 50 mg lepirudin.
what refludan looks like and contents of the pack refludan is a white powder for solution for injection or infusion supplied in a vial containing 50 mg lepirudin.

lepirudin isir minn ċellola li tkun irċeviet ġene (dna), li jagħmilha kapaċi li tipproduċi s- sustanza.
lepirudin is made by a cell that has received a gene (dna), which makes it able to produce the substance.

Ċirrożi tal- fwied tista’ taffettwa wkoll it-tneħħija mill-kliewi ta’ lepirudin.
liver cirrhosis may also affect the renal excretion of lepirudin.

lepirudin ([leu1, thr2]-63-desulfohirudin) huwa hirudin rikombinat derivat minn ċellolli tal-ħmira.
lepirudin ([leu1, thr2]-63-desulfohirudin) is a recombinant hirudin derived from yeast cells.

lepirudin jimblokka speċifikament sustanza msejħa trombina, li hija l-qofol tal-proċess sħiħ tat-taqgħqid tad-demm.
lepirudin specifically blocks a substance called thrombin, which is central for the complete process of blood clotting.

jista’ jkun neċessarju li pazjenti b’indeboliment tal-kliewi jiġu esklużi mill- kura b’kors ta’ lepirudin.
it may be necessary to exclude patients with renal impairment from treatment with lepirudin regimen.

lepirudin, is- sustanza attiva f’refludan, huwa kważi identiku għal hirudin, is-sustanza antikoagulanti prodotta mis- sangisugi.
the active substance in refludan, lepirudin, is nearly identical to hirudin, the anti-clotting substance produced by leeches.

dan jista’ jwassal għall- effetti antikoagulanti msaħħa ta’ lepirudin, possibilment minħabba dewmien fl-eliminazzjoni mill- kliewi ta’ kumplessi attivi ta’ lepirudin-antihirudin.
this may result in an enhanced anticoagulant effect of lepirudin, possibly due to delayed renal elimination of active lepirudin-antihirudin complexes.